BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15363641)

  • 21. Carnitine in type 2 diabetes.
    Mingrone G
    Ann N Y Acad Sci; 2004 Nov; 1033():99-107. PubMed ID: 15591007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carnitine and cardiac interstitium.
    Hülsmann WC; Peschechera A; Arrigoni-Martelli E
    Cardioscience; 1994 Jun; 5(2):67-72. PubMed ID: 7919051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency.
    Fingerhut R; Ensenauer R; Röschinger W; Arnecke R; Olgemöller B; Roscher AA
    Anal Chem; 2009 May; 81(9):3571-5. PubMed ID: 19323528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carnitine transport in rat heart slices: I. The action of thiol reagents on the acetylcarnitine/carnitine exchange.
    Sartorelli L; Ciman M; Siliprandi N
    Ital J Biochem; 1985; 34(4):275-81. PubMed ID: 3932251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa.
    Kobayashi D; Tamai I; Sai Y; Yoshida K; Wakayama T; Kido Y; Nezu J; Iseki S; Tsuji A
    Reproduction; 2007 Nov; 134(5):651-8. PubMed ID: 17965255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total acid soluble and insoluble carnitine levels in human brain tumors.
    Sandikci KS; Gümüstaş MK; Tüter Y; Kökoğlu E; Ozyurt E; Sözer V
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):49-57. PubMed ID: 10738901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of novel organic cation/carnitine transporter (OCTN2) in the mouse pancreas.
    Kai S; Yakushiji K; Yamauchi M; Ito C; Kuwajima M; Osada Y; Toshimori K
    Tissue Cell; 2005 Aug; 37(4):309-15. PubMed ID: 15896819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2.
    Todesco L; Bodmer M; Vonwil K; Häussinger D; Krähenbühl S
    Chem Biol Interact; 2009 Aug; 180(3):472-7. PubMed ID: 19539806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in carnitine in chronic uremia.
    Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
    J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A polarized localization of amino acid/carnitine transporter B(0,+) (ATB(0,+)) in the blood-brain barrier.
    Czeredys M; Mysiorek C; Kulikova N; Samluk Ł; Berezowski V; Cecchelli R; Nałecz KA
    Biochem Biophys Res Commun; 2008 Nov; 376(2):267-70. PubMed ID: 18771654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OCTN2-mediated transport of carnitine in isolated Sertoli cells.
    Kobayashi D; Goto A; Maeda T; Nezu J; Tsuji A; Tamai I
    Reproduction; 2005 Jun; 129(6):729-36. PubMed ID: 15923388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
    Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A
    Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OCTN3 is a mammalian peroxisomal membrane carnitine transporter.
    Lamhonwah AM; Ackerley CA; Tilups A; Edwards VD; Wanders RJ; Tein I
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1966-72. PubMed ID: 16288981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects.
    Fuda F; Narayan SB; Squires RH; Bennett MJ
    Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological rescue of carnitine transport in primary carnitine deficiency.
    Amat di San Filippo C; Pasquali M; Longo N
    Hum Mutat; 2006 Jun; 27(6):513-23. PubMed ID: 16652335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system.
    Peluso G; Nicolai R; Reda E; Benatti P; Barbarisi A; Calvani M
    J Cell Physiol; 2000 Mar; 182(3):339-50. PubMed ID: 10653600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium.
    Garrett Q; Xu S; Simmons PA; Vehige J; Flanagan JL; Willcox MD
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4844-9. PubMed ID: 18641280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of L-carnitine import into heart cells.
    Rigault C; Dias JV; Demarquoy J; Le Borgne F
    Biochimie; 2008 Mar; 90(3):542-6. PubMed ID: 17967426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein binding of L-carnitine family components.
    Marzo A; Arrigoni Martelli E; Mancinelli A; Cardace G; Corbelletta C; Bassani E; Solbiati M
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():364-8. PubMed ID: 1820909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.